GlassScriptPhysician profile
David F Mickey
NPI 1447710397
$6,238.99
in general payments reported to CMS, 2019-2025
21 companies · $2,252 in 2025
The $2,252 reported for 2025 was more than what 97% of Hospitalist providers received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $1,524 · 2024: $2,463 · 2025: $2,252.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,550 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $500 · Education: $189.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,549.67 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $500.00 |
| Education | $189.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,564.23 | 2023-2025 | Fasenra, Tezspire, Airsupra |
| Biocryst US Sales Co., LLC | $1,187.99 | 2023-2025 | Orladeyo |
| Glaxosmithkline, LLC. | $1,098.19 | 2023-2025 | Nucala, Arexvy |
| Regeneron Healthcare Solutions, INC. | $1,002.29 | 2023-2025 | Dupixent |
| Amgen INC. | $296.55 | 2024-2025 | Actimmune, Tezspire |
| Novartis Pharmaceuticals Corporation | $160.81 | 2023-2025 | Xolair |
| Csl Behring | $154.78 | 2023-2025 | Hizentra, Haegarda |
| Pharming Healthcare, INC. | $134.95 | 2024-2025 | Ruconest |
| Biocryst Pharmaceuticals, INC. | $130.79 | 2025 | Orladeyo |
| Fujifilm Healthcare Americas Corporation | $96.64 | 2023 | Utaswako Afp-L3 |
| Grifols USA, LLC | $96.06 | 2023-2025 | Prolastin-C Liquid, Xembify |
| Boehringer Ingelheim Pharmaceuticals, INC. | $66.16 | 2023-2024 | Ofev |
| Verona Pharma, INC. | $57.61 | 2025 | Ohtuvayre |
| Blueprint Medicines Corporation | $47.70 | 2024 | Ayvakit |
| Ars Pharmaceuticals Operations, INC. | $38.71 | 2025 | Neffy |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Greer Laboratories, INC. | $23.05 | 2024 | Palforzia |
| Lilly USA, LLC | $18.69 | 2025 | Ebglyss |
| Pfizer INC. | $18.36 | 2024 | |
| Inogen, INC. | $15.69 | 2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Horizon Therapeutics Plc | $15.20 | 2023 | Actimmune |
| Genentech USA, INC. | $14.54 | 2024 | Xolair |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Mickey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.